Regarding estrogen receptor, endometroid and mucinous endometrial adenocarcinoma shows strong and diffuse nuclear immunostaining while endocervical adenocarcinoma shows negative or weak focal immunostaining. This evidence concerns the gene ESR1 and endometrial mucinous adenocarcinoma.